GlycoMimetics (GLYC) Short Interest Ratio & Short Volume

Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 878,900 shares of GLYC short. Learn More on GlycoMimetics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLYC shares currently have a short interest ratio of 8.0. Learn More on GlycoMimetics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

GlycoMimetics saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 878,900 shares, a decline of 1.6% from the previous total of 893,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to GlycoMimetics: DiaMedica Therapeutics Inc. (0.64%), Atossa Therapeutics, Inc. (5.08%), Apollomics, Inc. (4.43%), Rani Therapeutics Holdings, Inc. (6.88%), Vistagen Therapeutics, Inc. (6.43%), Eton Pharmaceuticals, Inc. (3.36%), Carisma Therapeutics, Inc. (12.87%), 2seventy bio, Inc. (26.17%), Kinnate Biopharma Inc. (5.38%), Shattuck Labs, Inc. (0.79%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. GLYC shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is November, 15 2023.